Paper8782822
BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.
Sakamuro D and 3 others. Nat Genet, 1996. Cited by 325 papers, by iCite.
Cite this record
ConductScience Library. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Papers, record 8782822. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8782822
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrier Proteins | Major topic |
| Genes, Tumor Suppressor | Major topic |
| Nuclear Proteins | Major topic |
| Saccharomyces cerevisiae Proteins | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Adaptor Proteins, Signal Transducing | |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Cell Division | |
| Cell Line | |
| Cell Transformation, Neoplastic | |
| DNA Primers | |
| Fungal Proteins | |
| Genes, myc | |
| HeLa Cells | |
| Humans | |
| Microfilament Proteins | |
| Molecular Sequence Data | |
| Nerve Tissue Proteins | |
| Transformation, Genetic | |
| Tumor Cells, Cultured |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA09171 | NCI NIH HHS | United States | PubMed | PubMed | |
| CA10815 | NCI NIH HHS | United States | P01CA010815 | PubMed and NIH | NIH RePORTER |
| CA66179 | NCI NIH HHS | United States | PubMed | PubMed | |
| P30CA010815 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8782810 | MYC family ties. | https://conductscience.org/library/papers/8782810 |
Source PubMed
Cited by146
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 325 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650103 | RNA Splicing Dysregulation in Parkinson's Disease. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42650103 | PubMed |
| 41413653 | Phase separation drives cortical enrichment of the F-BAR proteins Rga7 and Rga8 to maintain cell integrity. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/41413653 | PubMed |
| 41250205 | tRNA-derived fragment tRF-24 drives CELF1 phase separation to promote oncogenic splicing in esophageal squamous cell carcinoma. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/41250205 | PubMed |
| 40808414 | Bridging autophagy and endolysosomal dysfunction: Role of bridging integrator 1 in Alzheimer's disease. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40808414 | PubMed |
| 40406608 | Conformational modulation of intrinsically disordered transactivation domains for cancer therapy. | PNAS Nexus | 2025 | https://conductscience.org/library/papers/40406608 | PubMed |
| 40392240 | Bend it like BIN1: how a membrane-curving adaptor protein shapes cardiac physiology. | Am J Physiol Heart Circ Physiol | 2025 | https://conductscience.org/library/papers/40392240 | PubMed |
| 40370532 | Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40370532 | PubMed |
| 40308061 | BIN1 gene replacement reverses BIN1-related centronuclear myopathy. | Mol Ther | 2025 | https://conductscience.org/library/papers/40308061 | PubMed |
| 40042903 | BIN1 reduction ameliorates DNM2-related Charcot-Marie-Tooth neuropathy. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40042903 | PubMed |
| 40016843 | BIN1 inhibited tumor growth, metastasis and stemness by ALDH1/NOTCH pathway in bladder carcinoma. | Hereditas | 2025 | https://conductscience.org/library/papers/40016843 | PubMed |
| 39859561 | Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD). | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859561 | PubMed |
| 39452773 | Molecular Dynamics Reveal Key Steps in BAR-Related Membrane Remodeling. | Pathogens | 2024 | https://conductscience.org/library/papers/39452773 | PubMed |
| 39171951 | BIN1 deficiency enhances ULK3-dependent autophagic flux and reduces dendritic size in mouse hippocampal neurons. | Autophagy | 2025 | https://conductscience.org/library/papers/39171951 | PubMed |
| 37859648 | An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes. | Front Neurol | 2023 | https://conductscience.org/library/papers/37859648 | PubMed |
| 37847429 | BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology. | Neurotox Res | 2023 | https://conductscience.org/library/papers/37847429 | PubMed |
| 37247278 | High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients. | Asian Pac J Cancer Prev | 2023 | https://conductscience.org/library/papers/37247278 | PubMed |
| 37217614 | Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. | Mol Biol Rep | 2023 | https://conductscience.org/library/papers/37217614 | PubMed |
| 36890396 | BIN1 in cancer: biomarker and therapeutic target. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/36890396 | PubMed |
| 36453088 | A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super-enhancers in maintaining EBV latency. | J Med Virol | 2023 | https://conductscience.org/library/papers/36453088 | PubMed |
| 35983068 | NF-κB in neurodegenerative diseases: Recent evidence from human genetics. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/35983068 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BIN1 | 274 | Swiss-Prot's references | https://conductscience.org/library/genes/274 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | U68485 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8782822
GET https://conductscience.org/api/papers/v1/8782822/cited_by?page=2